ATRA

Conviction 60HealthcareScan · Fri, Jun 26, 2026

ATRA$10.35+1.27%

ResistanceSupportVol 14Insider buyInsider sell

Vol MA14 91.99K

Mar 27Apr 15May 4May 20Jun 9Jun 26

Atara Biotherapeutics, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.atarabio.com ↗

Price10.35

Change+1.27%

Gap+1.57%

Rel volume1.33×

Avg volume90.26K

Avg $ vol913.7K

SMA 2010.14

SMA 508.44

SMA 2009.95

Price vs 50+22.56%

Price vs 200+4.03%

MA stackmixed

50/200 cross—

Supertrendup · 8.34

RSI (14)56

MACD hist-0.09

MACD cross—

Stoch %K / %D49 / 50

ADX (14)41

+DI / −DI24 / 12

RSI divergence—

MACD divergence—

ATR %+8.32%

ADR %7.73%

52w high18.09

52w low4.18

From 52w high-42.79%

Above 52w low+147.61%

New 52w highNo

SqueezeOn · 9d

Bollinger width15.91%

%B0.63

Donchian pos48.71%

Donchian high11.55

Donchian low9.21

AVWAP (52w high)8.79

vs AVWAP high+17.81%

AVWAP (52w low)9.14

vs AVWAP low+13.18%

OBV trendFlat

Chaikin MF (20)-0.17

Today vs 20d1.33×

Avg vol (14d)91.99K

Avg vol (20d)90.26K

Avg $ vol (20d)913.7K

Market cap—

RS 3m (vs SPY)+94.25%

RS 6m (vs SPY)-50.00%

RS line new highNo

Trend template4/8

Technical rank40.1

1 week+2.78%

1 month-1.80%

3 months+119.75%

6 months-40.86%

1 year+29.05%

YTD-41.76%

P/E2.81

P/B-2.47

P/S0.76

P/FCF-1.81

EPS2.57

Div yield—

ROE-87.61%

ROA163.46%

Debt/Eq—

Current2.16

EV/EBITDA2.20

Gross margin—

Net margin27.07%

Rev growth-6.33%

EPS growth138.28%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value83.63M

Revenue516K

Net income-4.14M

Gross profit—

Free cash flow-50.94M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out9.01M

Employees13

ListedThu, Oct 16, 2014

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeB

Conviction60 / 100

Pattern quality—

Tech rank40.1 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance12.00

Support6.59

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ATRA

All disclosures →

No recent disclosed trades by Congress in ATRA. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ATRA · 1 buy · 4 sells

Insider	Side	Shares	Value	Traded	Filed
Nguyen AnhCo President and CEO · Common Stock · 2026-05-18	Sell	5.24K	$48K	2026-05-18	2026-05-20
Grant-Huerta Yanina Chief Accounting Officer · Common Stock · 2026-05-18	Sell	2.41K	$22K	2026-05-18	2026-05-20
EcoR1 Capital, LLC 10% owner · Common Stock · 2026-05-07	Buy	507.41K	$4.7M	2026-05-07	2026-05-11
Panacea Innovation Ltd 10% owner · Common Stock · 2026-05-07	Sell	313.45K	$3.2M	2026-05-07	2026-05-11
Huang James Director · Common Stock · 2026-05-07	Sell	313.45K	$3.2M	2026-05-07	2026-05-11
Panacea Innovation Ltd 10% owner · Common Stock · 2026-05-07	Other	—	—	2026-05-07	2026-05-11
Huang James Director · Common Stock · 2026-05-07	Other	—	—	2026-05-07	2026-05-11

SEC filings

EDGAR filings in ATRA · 1 recent

EDGAR →

8-K8-KFri, Jun 12, 2026

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.